首页> 美国卫生研究院文献>Gut and Liver >Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)

【2h】

Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)

机译：选择抗肿瘤坏死因子药物时韩国克罗恩病患者偏爱的因素（选择研究）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/AimsTwo comparable anti-tumor necrosis factor (TNF) agents with different routes of administration (intravenous [iv] infliximab [IFX] vs subcutaneous [sc] adalimumab [ADA]) are available for patients with Crohn’s disease (CD) in Korea. This study aimed to identify the preferences of Korean CD patients for a specific anti-TNF agent and the factors contributing to the decision.

机译：背景/目的在韩国，患有克罗恩氏病（CD）的患者可以使用两种可比较的具有不同给药途径的抗肿瘤坏死因子（TNF）药物（静脉[iv]英夫利昔单抗[IFX]与皮下[sc]阿达木单抗[ADA]）。这项研究旨在确定韩国CD患者对特定抗TNF药物的偏爱以及做出决定的因素。

著录项

期刊名称 Gut and Liver
作者
Eun Soo Kim; Kyeong Ok Kim; Byung Ik Jang; Chang Kyun Lee; Hyo Jong Kim; Kang-Moon Lee; You Sun Kim; Chang Soo Eun; Sung-Ae Jung; Suk-Kyun Yang; Jun Lee; Tae-Oh Kim; Yunho Jung; Geom Seog Seo; Soon Man Yoon;
展开▼
作者单位

展开▼
年(卷),期 2016(10),3
年度 2016
页码 391–398
总页数 7
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Crohn disease Infliximab Adalimumab Preference;

机译：克罗恩病;英夫利昔单抗;阿达木单抗;偏爱;

相似文献

外文文献
中文文献
专利

1. Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study) [J] . Eun Soo Kim, Kyeong Ok Kim, Byung Ik Jang, Gut and Liver . 2016,第3期

机译：选择抗肿瘤坏死因子药物时，韩国克罗恩病患者偏爱的因素（选择研究）
2. Systematic assessment of factors influencing preferences of Crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL) [J] . VavrickaS.R., BenteleN., ScharlM., Inflammatory bowel diseases . 2012,第8期

机译：系统地评估影响克罗恩病患者选择抗肿瘤坏死因子药物（CHOOSE TNF TRIAL）的因素
3. ANTI-TUMOR NECROSIS FACTOR THERAPY PERSISTENCE IN PATIENTS WITH PERIANAL CROHN’S DISEASE AND LUMINAL CROHN’S DISEASE: A COMPARATIVE COHORT STUDY [J] . Fung M, Chin Koon Siw K, McCurdy J D Journal of the Canadian Association of Gastroenterology . 2021,第Supplementa1期

机译：抗肿瘤坏死因子治疗持续患者肛门克罗恩病和腔克罗恩病的患者：比较队列研究
4. Additive Effects of Simvastatin and Ranripril on Inflammatory Cytokines Interferon-y, Tumor Necrosis Factor-a, Interleukin-6 and C-Reactive Protein in Diabetic Patients with Hyperlipidemia and Coronary Artery Disease [C] . L. Tan, S. Tan, L. Berk, International Congress on Coronary Artery Disease . 2003

机译：辛伐他汀和RanRipril对糖尿病患者患者高脂血症和冠状动脉疾病炎症细胞因子干扰素-Y，肿瘤坏死因子-A，白细胞介素-6和C反应蛋白的添加剂效应
5. Predictors of Infection in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents [D] . Liu, Tasia 2017

机译：类风湿关节炎患者使用抗肿瘤坏死因子药物的感染预测因子
6. Comparative perianal fistula closure rates following autologous adipose tissue-derived stem cell transplantation or treatment with anti-tumor necrosis factor agents after seton placement in patients with Crohn’s disease: a retrospective observational study [O] . Min Young Park, Yong Sik Yoon, Jong Lyul Lee, 2021

机译：对比较的亚洲瘘闭合率在克罗恩病患者塞塞（塞氏症患者中）脂肪脂肪组织衍生的干细胞移植或用抗肿瘤坏死因子剂治疗：回顾性观察研究
7. Frequência de anticorpos aos agentes etiológicos da síndrome da imunodeficiência adquirida, sífilis, hepatites virais B e C e doença de Chagas em pacientes reumatológicos em tratamento com antifator de necrose tumoral (Tumor Necrosis Factor - TNF) Frequency of antibodies against the etiologic agents of acquired imunodeficiency syndrome, syphilis, hepatitis B and C, and Chagas' disease in patients with rheumatic diseases treated with anti-tumor necrosis factor [O] . Bárbara Santos Pires da Silva, Ana Cristina Endo, Ana Cristina de Medeiros, 2009

机译：Frequênciadeanticorpos aos agentesetiológicosdysíndromedimunodeficiênciaadquirida，sífilis，hepatites virais B e CedoençadeChagas empacientesreumatológicosmtratamento com antifator de necrose tumoral（Tumor Necrosis Factor - TNF）针对获得性免疫缺陷的病原体的抗体频率抗肿瘤坏死因子治疗风湿性疾病患者的综合征，梅毒，乙型和丙型肝炎及恰加斯病

相关主题

Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)

摘要

著录项

相似文献

相关主题

期刊订阅